CL
Insider buying
Carl L Gordon bought $15M of Scribe Therapeutics, Inc. (SCTX) stock
Carl L Gordon, Dir of Scribe Therapeutics, Inc. (SCTX), bought 1,000,000 shares of SCTX stock worth $15M, per an SEC Form 4 filed Jul 29, 2026.
The shares came through a private deal, not the open market.
The trade happened on Jul 23, 2026, 6 days before it was made public.
- Traded
- Jul 23, 2026
- Disclosed
- Jul 29, 2026
- Filing delay
- 6 days
- Role
- Dir
- Source
- SEC Form 4
More SCTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.